Holdings
Stempoint Capital LP
As of Sep 30, 2026, Stempoint Capital LP reported 71 positions worth US$502M. Largest: Scholar Rock Holding Corporation, Erasca, Inc. and Abivax SA. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Scholar Rock Holding Corporation | 689K | US$33.3M | +450K | Sep 30, 2026 |
| Erasca, Inc. | 2.26M | US$33.1M | +695K | Sep 30, 2026 |
| Abivax SA | 279K | US$27.7M | −4,259 | Sep 30, 2026 |
| Tango Therapeutics, Inc. | 989K | US$24.7M | −234K | Sep 30, 2026 |
| Roivant Sciences Ltd. | 641K | US$23.5M | +293K | Sep 30, 2026 |
| First Tracks Biotherapeutics, Inc. | 650K | US$23M | +27,201 | Sep 30, 2026 |
| Enliven Therapeutics, Inc. | 330K | US$15.1M | −16,438 | Sep 30, 2026 |
| Adaptive Biotechnologies Corporation | 464K | US$13.4M | new | Sep 30, 2026 |
| Dianthus Therapeutics, Inc. | 151K | US$13.3M | −50,075 | Sep 30, 2026 |
| Sensei Biotherapeutics, Inc. | 405K | US$12M | new | Sep 30, 2026 |